Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

NCT03507829 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

263

Enrollment

OTHER

Sponsor class

Conditions

Hyperglycemia

Interventions

DRUG: Human insulin isophane, Humulin N (Eli Lilly)
DRUG: Standard of care
DRUG: Insulin lispro, Humalog (Eli Lilly) in insulin pump

Sponsor

Medical University of Vienna

Collaborators

[object Object]
[object Object]
[object Object]